Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05

March 14, 2012 4:15 PM EDT Send to a Friend
Get Alerts NABI Hot Sheet
Price: $1.80 --0%

EPS Growth %: -71.4%

Financial Fact:
Revenue: 29.5M

Today's EPS Names:
CBNK, HTLD, GRC, More
Trade NABI Now!
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment